US President Donald Trump has proposed raising tariffs on imported medicines to 150 percent, and potentially to 250 percent, as a way to boost US domestic production. How would such a policy affect Taiwan’s pharmaceutical market?
About 75 percent of medicines in Taiwan are imported. Much less is exported to the US. Many of Taiwan’s biopharmaceutical companies have established operations in the US. If the US government raises tariffs on drug imports, it would benefit these Taiwan-backed US companies to become even more competitive.
In Taiwan, medical institutions apply to the National Health Insurance Administration (NHIA) to register drug prices according to reimbursement benefits and payment standards. These institutions negotiate prices with pharmaceutical companies, often driving them down and squeezing profits. For instance, under the National Health Insurance system, Plavix — a drug used to prevent atherosclerosis — costs NT$36, compared with the equivalent of NT$239 in the US.
If higher tariffs disrupt the global pharmaceutical supply chain by raising costs and reducing output, and if purchase prices in Taiwan remain capped, companies might prioritize selling to higher-margin markets. Under free-market conditions, this could lead to shortages of brand-name drugs in Taiwan.
While brand-name and generic drugs are essentially the same in terms of ingredients, dosage and form, the former carry higher prices due to research and development costs. Generics, produced after patents expire, must still meet the Good Manufacturing Practice standards set by the Pharmaceutical Inspection Co-operation Scheme, ensuring safety and quality equivalent to the originals.
To mitigate the risk of brand-name drug shortages, Taiwan’s pharmaceutical industry must strengthen its capacity to produce generics, reducing reliance on imported brands. Locally manufactured generics could serve as a vital substitute in the event of supply disruptions.
Yeh Yu-cheng is a civil servant at the Public Health Bureau
Translated by Lai Wen-chieh
On Sept. 3 in Tiananmen Square, the Chinese Communist Party (CCP) and the People’s Liberation Army (PLA) rolled out a parade of new weapons in PLA service that threaten Taiwan — some of that Taiwan is addressing with added and new military investments and some of which it cannot, having to rely on the initiative of allies like the United States. The CCP’s goal of replacing US leadership on the global stage was advanced by the military parade, but also by China hosting in Tianjin an August 31-Sept. 1 summit of the Shanghai Cooperation Organization (SCO), which since 2001 has specialized
In an article published by the Harvard Kennedy School, renowned historian of modern China Rana Mitter used a structured question-and-answer format to deepen the understanding of the relationship between Taiwan and China. Mitter highlights the differences between the repressive and authoritarian People’s Republic of China and the vibrant democracy that exists in Taiwan, saying that Taiwan and China “have had an interconnected relationship that has been both close and contentious at times.” However, his description of the history — before and after 1945 — contains significant flaws. First, he writes that “Taiwan was always broadly regarded by the imperial dynasties of
The Chinese Communist Party (CCP) will stop at nothing to weaken Taiwan’s sovereignty, going as far as to create complete falsehoods. That the People’s Republic of China (PRC) has never ruled Taiwan is an objective fact. To refute this, Beijing has tried to assert “jurisdiction” over Taiwan, pointing to its military exercises around the nation as “proof.” That is an outright lie: If the PRC had jurisdiction over Taiwan, it could simply have issued decrees. Instead, it needs to perform a show of force around the nation to demonstrate its fantasy. Its actions prove the exact opposite of its assertions. A
A large part of the discourse about Taiwan as a sovereign, independent nation has centered on conventions of international law and international agreements between outside powers — such as between the US, UK, Russia, the Republic of China (ROC) and Japan at the end of World War II, and between the US and the People’s Republic of China (PRC) since recognition of the PRC as the sole representative of China at the UN. Internationally, the narrative on the PRC and Taiwan has changed considerably since the days of the first term of former president Chen Shui-bian (陳水扁) of the Democratic
RSS